BNB Plus Corp. (BNBX)
Manufactures synthetic DNA and RNA for pharmaceutical and diagnostic companies.
$0.09+0.21%Financial Services
StockGlow Score
Bearish
BearishBullish
1 year ago-98.0%
The outlook
BNBX is trading near its 52-week lows at $0.09, well below both its 50- and 200-day moving averages, signaling a weak recent trend. The stock shows minimal analyst coverage and carries a bearish sentiment score. Its trailing P/E is not meaningful, suggesting the company is not currently profitable on an earnings basis.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$647,750
52-wk high
$7.15
52-wk low
$0.07
50-day avg
$0.36
200-day avg
$1.40
Trailing P/E
0.0